|
Report Date : |
11.05.2012 |
IDENTIFICATION
DETAILS
|
Name : |
HEALTH BIOTECH
LIMITED (w.e.f. 03.08.2007) |
|
|
|
|
Formerly Known as: |
HEALTH BIOTECH
PRIVATE LIMITED |
|
|
|
|
Registered Office : |
SCO 162-164, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation : |
24.04.2001 |
|
|
|
|
Com. Reg. No.: |
53-24356 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24233CH2001PLC024356 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
PTLH11595D |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AABCH1876K |
|
|
|
|
Legal Form : |
A closely held public limited liability company. |
|
|
|
|
Line of Business : |
Manufacturer and
Exporter of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
400
(Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (45) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 1450532 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually Correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is an established company having satisfactory track. Trade relations
are fair. Business is active. Payments are reported to be usually correct and
as per commitments. The company can be considered normal for business dealings at usual
trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Mr. Vishal |
|
Designation : |
Account Manager |
|
Contact No.: |
91-172-4685300 |
|
Date : |
10.05.2012 |
LOCATIONS
|
Registered Office/ Factory : |
SCO 162-164, |
|
Tel. No.: |
91-172-3241310 /
2622688 / 2623369 |
|
Fax No.: |
91-172-2620688 |
|
E-Mail : |
|
|
Website : |
|
|
Location: |
Owned |
|
|
|
|
Factory: |
Baddi, Himachal Pradesh,
India |
DIRECTORS
AS ON 30.09.2011
|
Name : |
Mr. Paramjit
Arora |
|
Designation : |
Director |
|
Address : |
# 1376, Sector –
40 B, |
|
Date of Birth/Age : |
11.09.1969 |
|
Qualification : |
D. Pharma |
|
Date of Appointment : |
24.04.2001 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U70101CH1998PTC022082 |
MAXPRO ESTATES PRIVATE
LIMITED |
Director |
20/10/2000 |
20/10/2000 |
21/12/2011 |
Active |
NO |
|
2 |
U24233CH2001PLC024356 |
HEALTH BIOTECH LIMITED |
Director |
24/04/2001 |
24/04/2001 |
- |
Active |
NO |
|
3 |
U24231CH2004PTC027353 |
PROHEALTH VITAMINS PRIVATE
LIMITED |
Director |
04/08/2004 |
04/08/2004 |
- |
Active |
NO |
|
4 |
U24230CH2005PTC028347 |
AMRIT REMEDIES PRIVATE
LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
5 |
U24230CH2005PTC028345 |
CORAL PHARMACEUTICALS
PRIVATE LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
6 |
U24232CH2007PTC030731 |
HUMAN PHARMACIA PRIVATE
LIMITED |
Director |
08/03/2007 |
08/03/2007 |
- |
Active |
NO |
|
7 |
U24232CH2007PTC030852 |
MANCURE DRUGS PRIVATE
LIMITED |
Director |
19/06/2007 |
19/06/2007 |
- |
Active |
NO |
|
8 |
U24100CH2008PLC031087 |
RESCUERS LIFE SCIENCES
LIMITED |
Director |
12/02/2008 |
12/02/2008 |
- |
Active |
NO |
|
Name : |
Mrs. Rohini Raman
|
|
Designation : |
Director |
|
Address : |
# 1376, Sector –
40 B, |
|
Date of Birth/Age : |
07.02.1981 |
|
Date of Appointment : |
03.07.2007 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24233CH2001PLC024356 |
HEALTH BIOTECH LIMITED |
Director |
30/06/2008 |
30/06/2008 |
- |
Active |
NO |
|
Name : |
Mr. Gaurav Chawla |
|
Designation : |
Director |
|
Address : |
H. No. 1018,
Sector – 12A, Pankula, Haryana – 134 009, |
|
Date of Birth/Age : |
07.02.1981 |
|
Date of Appointment : |
03.07.2007 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24230CH2005PTC028349 |
G S REMEDIES PRIVATE
LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
2 |
U24233CH2001PLC024356 |
HEALTH BIOTECH LIMITED |
Director |
03/07/2007 |
03/07/2007 |
- |
Active |
NO |
|
3 |
U24100CH2008PLC031087 |
RESCUERS LIFE SCIENCES
LIMITED |
Director |
12/02/2008 |
12/02/2008 |
- |
Active |
NO |
|
Name : |
Ms. Renu Arora |
|
Designation : |
Director |
|
Address : |
1264,Sector 8-C, Chandigarh |
|
Date of Birth/Age : |
12.06.1975 |
|
Date of Appointment : |
24.04.2001 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24233CH2001PLC024356 |
HEALTH BIOTECH LIMITED |
Director |
24/04/2001 |
24/04/2001 |
- |
Active |
NO |
|
2 |
U24231CH2004PTC027353 |
PROHEALTH VITAMINS PRIVATE
LIMITED |
Director |
04/08/2004 |
04/08/2004 |
- |
Active |
NO |
|
3 |
U24230CH2005PTC028346 |
ARP PHARMACEUTICALS
PRIVATE LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
4 |
U24230CH2005PTC028347 |
AMRIT REMEDIES PRIVATE
LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
5 |
U24230CH2005PTC028345 |
CORAL PHARMACEUTICALS
PRIVATE LIMITED |
Director |
04/05/2005 |
04/05/2005 |
- |
Active |
NO |
|
6 |
U24232CH2007PTC030731 |
HUMAN PHARMACIA PRIVATE LIMITED
|
Director |
08/03/2007 |
08/03/2007 |
- |
Active |
NO |
|
7 |
U24232CH2007PTC030852 |
MANCURE DRUGS PRIVATE
LIMITED |
Director |
19/06/2007 |
19/06/2007 |
- |
Active |
NO |
|
8 |
U24100CH2008PLC031087 |
RESCUERS LIFE SCIENCES LIMITED
|
Director |
12/02/2008 |
12/02/2008 |
- |
Active |
NO |
|
Name : |
Mr. Ravi
Sankar |
|
Designation : |
Director |
|
Address : |
D. No. 4-118/46, Swaroop Nagar, Venkateswaratemple Road,
Uppal, Hyderabad |
|
Date of Appointment : |
17/02/2011 |
Other Directorship:
|
S.No. |
CIN |
Name of the Company |
Current designation of the director |
Date of appointment at current designation |
Original date of appointment |
Date of cessation |
Company Status |
Defaulting status |
|
1 |
U24233CH2001PLC024356 |
HEALTH BIOTECH LIMITED |
Director |
17/02/2011 |
17/02/2011 |
- |
Active |
NO |
|
Name : |
Mr. Jitendra
Sehrawat |
|
Designation : |
Director |
|
Address : |
31/19 Huda Plots Panchkula |
|
Date of Birth/Age : |
24.06.1973 |
|
Date of Appointment : |
13.10.2009 |
|
Date of Ceasing: |
01.06.2010 |
MAJOR SHAREHOLDERS
AS ON 30.09.2011
|
Names of
Shareholders |
|
No. of Shares |
|
Mr. Paramjit
Arora |
|
4645832 |
|
Ms. Renu Arora |
|
2444028 |
|
Mr. Gaurav chawla
|
|
100 |
|
Mr. Des Raj
Chawla |
|
10 |
|
Mr. Raj Rani |
|
10 |
|
Mr. Chanranjit
Singh |
|
10 |
|
Mrs. Manmohan
Kaur |
|
10 |
|
TOTAL |
|
7090000 |
AS ON
30.09.2011
Equity share breakup (percentage of total equity)
|
Category |
Percentage |
|
Directors or relatives of directors |
100.00 |
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer and
Exporter of Pharmaceutical Products. |
|
|
|
|
Products : |
|
|
Export : |
|
|
Product : |
Pharmaceutical Products |
|
Country : |
|
|
|
|
|
Import |
|
|
Product : |
Raw Material |
|
Country : |
|
|
|
|
|
Terms : |
|
|
Selling : |
Advance |
|
|
|
|
Purchasing : |
Advance |
PRODUCTION STATUS AS ON 31.03.2011
|
Particulars |
Units |
|
Installed
Capacity |
Actual
Production |
|
Injections, Eye/Ear Drops |
Per shift in units. |
|
297.800 Millions Units |
1614.41 |
|
|
|
|
|
|
GENERAL
INFORMATION
|
Suppliers: |
Nectar Life
Sciences |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Customers : |
·
Manufacturer ·
Retailers
·
Cadila
Healthcare ·
Sanat
Products Limited ·
Vetoquim
India Limited |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
No. of Employees : |
400
(Approximately) |
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Bankers : |
|
|||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Rajesh Aggarwal
and Associates Chartered Accountant |
|
Address : |
S.C.O. 40, 2nd
Floor, Sector – 31D, |
|
Tel. No.: |
91-172-5012305 |
|
|
|
|
Related Party: |
· Amrit Remedies Private Limited · ARP Pharmaceuticals Private Limited · Coral Pharmaceuticals. Private Limited · Human Pharmacia Private Limited · Mancure Drugs Private Limited · Prohealth Vitamins Private Limited · Rescures Life sciences Limited · G.S Remedies Private Limited · D.S Remedies Private Limited · Maxpro Estates Private Limited |
CAPITAL STRUCTURE
AS ON 30.09.2011
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
7500000 |
Equity Shares |
Rs.10/- each |
Rs. 75.000 Millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
|
|
|
|
|
7090000 |
Equity Shares |
Rs.10/- each |
Rs.70.900
Millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
70.900 |
69.650 |
68.650 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.145 |
|
|
3] Reserves & Surplus |
291.733 |
217.213 |
159.116 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
362.633 |
286.863 |
227.911 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
379.107 |
309.306 |
314.163 |
|
|
2] Unsecured Loans |
38.388 |
36.000 |
1.000 |
|
|
TOTAL BORROWING |
417.495 |
345.306 |
315.163 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
780.128 |
632.169 |
543.074 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
342.147 |
313.402 |
253.917 |
|
|
Capital work-in-progress |
0.000 |
26.694 |
21.548 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
39.637 |
26.781 |
0.000 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
385.433
|
221.112 |
162.834
|
|
|
Sundry Debtors |
148.047
|
112.523 |
215.848
|
|
|
Cash & Bank Balances |
10.243
|
17.702 |
10.393
|
|
|
Other Current Assets |
0.000
|
0.000 |
0.000
|
|
|
Loans & Advances |
42.632
|
6.422 |
61.171
|
|
Total
Current Assets |
586.355
|
357.759 |
450.246 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
126.312
|
78.688 |
184.323
|
|
|
Other Current Liabilities |
82.133
|
40.164 |
|
|
|
Provisions |
0.000
|
0.000 |
0.000
|
|
Total
Current Liabilities |
208.445
|
118.852 |
184.323
|
|
|
Net Current Assets |
377.910
|
238.907 |
265.923
|
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
20.434 |
26.385 |
1.686 |
|
|
|
|
|
|
|
|
TOTAL |
780.128 |
632.169 |
543.074 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Income |
1108.937 |
770.982 |
613.478 |
|
|
|
Other Income |
7.930 |
2.666 |
2.802 |
|
|
|
TOTAL (A) |
1116.867 |
773.648 |
616.280 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Cost of Sales |
857.396 |
556.837 |
470.793 |
|
|
|
Manufacturing Expenses |
9.294 |
11.266 |
27.585 |
|
|
|
Administrative Expenses |
31.330 |
29.444 |
23.300 |
|
|
|
Selling and Distribution Expenses |
50.966 |
32.934 |
6.904 |
|
|
|
Increase / Decrease in Stock |
0.000 |
0.000 |
(42.847) |
|
|
|
TOTAL (B) |
948.986 |
630.481 |
485.735 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
167.881 |
143.167 |
130.545 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
51.562 |
41.464 |
37.373 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
116.319 |
101.703 |
93.172 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
40.648 |
31.831 |
28.835 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
75.671 |
69.872 |
64.337 |
|
|
|
|
|
|
|
|
|
Less |
TAX (I) |
0.000 |
0.000 |
7.292 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-I) (J) |
75.671 |
69.872 |
57.045 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
NA |
NA |
105.396 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
0.000 |
195.577 |
146.481 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
3.612 |
23.116 |
0.925 |
|
|
TOTAL EARNINGS |
3.612 |
23.116 |
0.925 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Raw Materials |
NA |
NA |
13.855 |
|
|
TOTAL IMPORTS |
NA |
NA |
13.855 |
|
|
Particulars |
|
|
31.03.2012 |
|
Sales Turnover |
|
|
1300.000 |
|
|
|
|
|
Expected Sales (2010-2011) : Rs.2000.000 Millions
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
6.77 |
9.03
|
9.25
|
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
6.82 |
9.06
|
10.48
|
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
8.15 |
10.41
|
9.13
|
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.21 |
0.24
|
0.28
|
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.73 |
1.62
|
2.19
|
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.81 |
3.01
|
2.44
|
LOCAL AGENCY FURTHER INFORMATION
Note :
The address of the
registered office of the company has been shifted from SCO – 88, Sector – 44C,
|
Check List by
Info Agents |
Available in
Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
Yes |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter's background |
Yes |
|
8) No. of employees |
Yes |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
Yes |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
Yes |
|
20) Export / Import details (if
applicable) |
Yes |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
-- |
|
23) Banking Details |
Yes |
|
24) Banking facility details |
Yes |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
Yes |
|
30) Major Shareholders, if available |
Yes |
FORM 8:
|
Corporate
identity number of the company |
U24233CH2001PLC024356 |
|
Name of the
company |
HEALTH
BIOTECH LIMITED |
|
Address of the registered
office or of the principal place of
business in |
SCO 162-164, |
|
This form is for |
Modification of
charge |
|
Type of charge |
Immovable
property Book debts Movable property
(not being pledge) Others |
|
Particular of
charge holder |
State Bank Of |
|
Nature of
instrument creating charge |
Supplemental Deed
of Gurantee (C4a), Supplemental Agreement of Plegde, Letter of Individual
Limits(C5), Agreement Cum Indeminity, Omnibus Counter Gurantee |
|
Date of
instrument Creating the charge |
10/12/2010 |
|
Amount secured by
the charge |
Rs.474.500
Millions |
|
Brief of the
principal terms an conditions and extent and operation of the charge |
Rate of interest : CC (HYP) @6.50% Above Base Rate Tl1 To 3 And OTL @4.50% Above Sbar With Reset Clause
Every 2 Years For Term Loan and With Reset Clause for Cc Every Year Linked tO
SBAR Terms of repayment : As Per Existing
Terms Cc Repayable On
Demand Margin : Stocks 25% Receivables 40% Lc/Bg 20% Forward Contract
2% Extent and operation of the charge : 100% Other : As Per Existing
Terms |
|
Short particulars
of the property charged (Including location of the property) |
Hypothecation Of
All Current Assets Including Raw Material, Wip, Finished Goods, Consumables,
Book Debts And Hyp of Vehicle Purchased Hyp of All Fixed Assets of The Company Present And
Future Equitable
Mortgage of Factory Land 3 Bighas 8
Biswas Incld Building Thereon Situated At Near Clarks Hotel, Baddi Nalagarh
Road Baddi In The Name of The Company Equitable
Mortgage of Factory Land 1 Bighas Incld Building Thereon Situated At Near
Clarks Hotel, Baddi Nalagarh Road Baddi In The Name of The Company Equitable
Mortgage of Factory Land 1 Bighas Incld Building Thereon Situated At Near
Clarks Hotel, Baddi Nalagarh Road Baddi In The Name Of The Company Collateral
Security of Land Measuring 5.26 Bighas
(Four Properties) Situated At Near Clarks Hotel, Baddi Nalagarh Road Baddi
(Distt Solan) Pledge Of 30%
Shares Of The Company |
|
Date of
instrument modifying the charge |
03/02/2010 |
|
Particulars of
the present modification |
Increase Of
Overall Limit From Rs 442.900 Millions To Rs 474.500 Millions With Break Up
As Follows:- From(Millions) To (Millions) Cc(Hyp) 195.000 280.000 Cc(Bd) (110.000) (130.000) Within Cc Hyp Epc 1 1 Fbp 5.000 5.000 Tl 9.54 98.800 Ilc 6.50 65.000 Bg 1.5 15.000 Fc 0.07 0.700 Total Fb+Nfb Limit 474.500 Millions |
FIXED ASSETS :
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners, controlling
shareholders or senior officers as terrorist or terrorist organization or whom
notice had been received that all financial transactions involving their assets
have been blocked or convicted, found guilty or against whom a judgement or
order had been entered in a proceedings for violating money-laundering,
anti-corruption or bribery or international economic or anti-terrorism sanction
laws or whose assets were seized, blocked, frozen or ordered forfeited for
violation of money laundering or international anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper payments
to government officials for engaging in prohibited transactions or with
designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l Anti-Money
Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws, regulations
or policies that prohibit, restrict or otherwise affect the terms and
conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 53.33 |
|
|
1 |
Rs. 86.10 |
|
Euro |
1 |
Rs. 69.06 |
INFORMATION DETAILS
|
Information
Gathered by : |
SBA |
|
|
|
|
Report Prepared
by : |
SDA |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
5 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
5 |
|
--PROFITABILIRY |
1~10 |
5 |
|
--LIQUIDITY |
1~10 |
5 |
|
--LEVERAGE |
1~10 |
5 |
|
--RESERVES |
1~10 |
5 |
|
--CREDIT LINES |
1~10 |
5 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
Yes |
|
--LITIGATION |
YES/NO |
No |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
No |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
No |
|
--EXPORT ACTIVITIES |
YES/NO |
Yes |
|
--AFFILIATION |
YES/NO |
Yes |
|
--LISTED |
YES/NO |
No |
|
--OTHER MERIT FACTORS |
YES/NO |
Yes |
|
TOTAL |
|
45 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.